Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate

American Journal of Transplantation

Volumn 9, Issue 5, 2009, Pages 1243-1248

  Nabors, L B ^a   Palmer, C A ^a,b   Julian, B A ^c   Przekwas, A M ^c   Kew, C E ^c  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Brain tumors; Chemotherapy; PTLD; Renal transplants

Indexed keywords

ACICLOVIR; CYCLOSPORIN; FOLINATE CALCIUM; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; TUMOR BIOPSY; VIRUS INFECTION;

CENTRAL NERVOUS SYSTEM DISEASES; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; METHOTREXATE; MYELOPROLIFERATIVE DISORDERS; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 65249106067     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02598.x     Document Type: Article

References (16)

1. Aulisio MP, Devita M, Luebke D. Taking values seriously: Ethical challenges in organ donation and transplantation for critical care professionals. Crit Care Med 2007 35 (2 Suppl S95 S101.
2. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988 25 : 367 472.
3. Shapiro R, Nalesnik M, McCauley J et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 68 : 1851 1854.
4. Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 2004 121 : 246 253.
5. Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995 59 : 240 244.
6. Leblond V, Dhedin N, Mamzer Bruneel MF et al. Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol 2001 19 : 772 778.
7. Eichler AF, Batchelor TT. Primary central nervous system lymphoma: Presentation, diagnosis and staging. Neurosurg Focus 2006 21 : E15.
8. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr., Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988 62 : 2461 2465.
9. Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006 24 : 1281 1288.
10. Batchelor T, Carson K, O'Neill A et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07. J Clin Oncol 2003 21 : 1044 1049.
11. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003 76 : 1289 1293.
12. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004 4 : 222 230.
13. Batchelor DJ, Bright SR, Ibarrola P, Tzannes S, Blackwood L. Long-term survival after combination chemotherapy for bilateral renal malignant lymphoma in a dog. N Z Vet J 2006 54 : 147 150.
14. Ganne V, Siddiqi N, Kamaplath B et al. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant 2003 17 : 417 422.
15. Taj MM, Messahel B, Mycroft J et al. Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children. Br J Haematol 2008 140 : 191 196.
16. Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992 23 : 9 17.